Large-scale study “The Russian Far East: Industry, Public-Private Partnerships, and Government Support Measures” prepared specifically for the Eastern Economic Forum 2025.
The forum "Localization in Manufacturing" will take place on September 18-19. The event is dedicated to the localization challenges faced by all Russian goods manufacturers since January 1, 2025, following the enactment of Government Decree No. 1875.
On 7 July 2025, the President of the Russian Federation has signed the Federal Law No. 186-FZ of 07.07.2025 “On Amendments to Article 21 of the Federal Law “On Limited Liability Companies" (hereinafter the “Law”), which provides for amendments to the Federal Law No. 14-FZ of 08.02.1998 “On Limited Liability Companies” (hereinafter the “LLC Law”) taking effect on 1 September 2025 regarding the possibility of excluding the pre-emptive right to purchase a share or a part thereof.
On 7 July 2025, the President of the Russian Federation has signed the Federal Law No. 186-FZ of 07.07.2025 “On Amendments to Article 21 of the Federal Law “On Limited Liability Companies" (hereinafter the “Law”), which provides for amendments to the Federal Law No. 14-FZ of 08.02.1998 “On Limited Liability Companies” (hereinafter the “LLC Law”) taking effect on 1 September 2025 regarding the possibility of excluding the pre-emptive right to purchase a share or a part thereof.
On June 24, 2025, the President of the Russian Federation signed Federal Law No. 178-FZ "On Amendments to Part One and Article 846 of Part Two of the Civil Code of the Russian Federation" ("Law"), which introduces amendments to the Civil Code of the Russian Federation ("Civil Code"), allowing one legal entity to be the sole participant or shareholder of another company, even if both are having the sole person in it.
Join us and fellow experts to explore opportunities and challenges of doing business in Iran.
April 10th, 2025 annual conference Pharmaceuticals – 2025: Legal Issues will take place in Moscow organized by Pravo.ru. Lidings lawyers take an active part in the event’s program.
As a strategic partner of the conference, we aimed to make the program rich and actual. Together with pharmaceutical industry experts and lawyers, we will discuss how the market has changed in 2024 and what awaits us in 2025.
We are pleased to announce the appointment of two new partners and counsel!
The site uses cookie technology to ensure optimal performance, analyze usage and improve user experience. By continuing to use the site, you consent to the placement of cookies on your device on the terms set out in the Privacy Policy.
To ensure optimal performance, analyze usage and improve user experience, the website may use web analytics systems (including Yandex.Metrica), which may place cookies on your device.
By continuing to use the website, you agree to the use of these technologies and the placement of cookies. You can delete cookies from your device through your browser settings and you can block the placement of cookies, however, in doing so, some website features may not be available due to the engine's technological limitations.
You can find more information in the Privacy Policy.